13th Tumour Models London Summit 2024, December 4-5, 2024
Conference
genOway presentation
Event
-
December 4, 2024
genOway's presentation on Wednesday, December 4, 2024 | 1:30 p.m. GMT:
Presence of myeloid and lymphoid cells are key for translational tumor biology, efficacy and safety assessment in humanized mouse models
- Outlining BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
- Investigating human immune cell recruitment into tumor microenvironment
- Studying myeloid cell functionality and their contribution to translatable safety assessment of therapies
13th Tumour Models London Summit 2024, December 4-5, 2024
Get in touch
Let us know how we can help
Other news & events
Scientific excellence
From model design to experimental results
Featured in 600+ scientific articles
Collaborative approach
Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions
Robust validation data on catalog models
Generated with biopharma partners and in-house
Innovative technologies
and guaranteed freedom to operate
Easy access to models
Models with certified health status from professional breeders in US and Europe